- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Echo Therapeutics (NASDAQ:ECTE): Current price $0.79
The firm reported that the United States Patent and Trademark Office has issued U.S. Patent No. 8,386,027, “Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery,” for its Prelude SkinPrep System, which is the skin permeation component of the Symphony CGM System. Echo Therapeutics is a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.